Mitsubishi Pharma Europe Ltd was established in 2001 with headquarters based in London. On 1st June 2014, the company name changed to Mitsubishi Tanabe Pharma Europe Ltd (MTPE) in order to unify the company name with that of our parent company, Mitsubishi Tanabe Pharma Corporation (MTPC). We also have business operations in Germany, Austria and Switzerland, our subsidiary company, Mitsubishi Tanabe Pharma GmbH, is responsible for the distribution, sales and marketing activities in the German, Austrian and Swiss territories. We are engaged in the management of clinical research and commercial operations on behalf of Mitsubishi Tanabe Pharma Corporation, in the European Union (EU) and other related European territories.